The impact of ustekinumab on extraintestinal manifestations of Crohns disease: A post hoc analysis of the UNITI studies

机译：Ustekinumab对克罗恩疾病的兴奋性表现的影响：闭合学研究的后HOC分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

This post hoc analysis of the UNITI studies found ustekinumab (UST) did not significantly improve overall extraintestinal manifestations (EIMs) of Crohn's disease compared to placebo‐treated patients at weeks 6 and 52.

机译：与安慰剂治疗的患者在第6周和52周内发现，该闭合性研究发现Ustekinumab（UST）没有显着改善Crohn疾病的整体蛋精表现（EIP）。

著录项

期刊名称 United European Gastroenterology Journal
作者
Neeraj Narula; Achuthan Aruljothy; Emily C. L. Wong; Ravi Homenauth; Abdul‐Aziz Alshahrani; John K. Marshall; Walter Reinisch;
展开▼
作者单位

展开▼
年(卷),期 2021(9),5
年度 2021
页码 581–589
总页数 9
原文格式 PDF
正文语种
中图分类肠道病毒与肝炎病毒;肝及胆疾病;肠疾病;
关键词

机译：克罗恩氏病;提外表现;分辨率;Ustekinumab;

相似文献

外文文献
中文文献
专利

1. The trend in newly diagnosed Crohn's disease and extraintestinal manifestations of Crohn's disease in central China: A retrospective study of a single center [J] . European journal of gastroenterology and hepatology . 2012,第12期

机译：中国中部新诊断克罗恩病的趋势和克罗恩病的肠外表现：单个中心的回顾性研究
2. Adalimumab Reduces Extraintestinal Manifestations in Patients with Crohn’s Disease: A Pooled Analysis of 11 Clinical Studies [J] . Edouard J. Louis, Walter Reinisch, David A. Schwartz, Advances in therapy. . 2018,第4期

机译：Adalimumab减少了克罗恩病患者的外来体表现：11项临床研究的汇总分析
3. Efficacy and Safety of Dose Adjustment and Delayed Response to Ustekinumab in Moderate - Severe Crohn's Disease Patients: Results from the IM-UNITI Maintenance Study [J] . Sands Bruce, Gasink Chris, Jacobstein Doug, The American Journal of Gastroenterology . 2016,第Suppla1期

机译：剂量调整和对乌斯妥单抗延迟反应在中重度克罗恩病患者中的疗效和安全性：IM-UNITI维持研究的结果
4. Characterizing Microbiome Stability and Metabolic Activities in Post-Surgery Crohn's Diseased Human Gut by High Performance Mass Spectrometry [C] . Robert Hettich, Alison Erickson, Chongle Pan, American Society for Mass Spectrometry Conference on Mass Spectrometry and Allied Topics . 2013

机译：通过高性能质谱法在手术后克罗恩患病人体肠道中表征微生物组稳定性和代谢活动
5. Quantifying disease progression trajectory and investigating the impact of early initiation of biologic therapy in patients with Crohn's disease using the Lemann index of cumulative bowel damage. [D] . Panchal, Hina J. 2017

机译：使用累积肠损伤的Lemann指数量化疾病进展轨迹，并研究早期开始生物治疗对克罗恩病患者的影响。
6. A147 RESPONSE AND REMISSION AFTER 16 WEEKS OF USTEKINUMAB– AN ALL PATIENTS ANALYSIS FROM THE UNITI CROHN’S STUDIES [O] . J F Colombel, S Sloan, C Gasink, 2018

机译：AUSKINUKAB 16周后的反应和缓解-根据UNITI CROHN的研究进行的所有患者分析
7. The impact of ustekinumab on extraintestinal manifestations of Crohn's disease: A post hoc analysis of the UNITI studies [O] . Neeraj Narula, Achuthan Aruljothy, Emily C. L. Wong, 2021

机译：Ustekinumab对克罗恩疾病的兴奋性表现的影响：闭合学研究的后HOC分析

The impact of ustekinumab on extraintestinal manifestations of Crohns disease: A post hoc analysis of the UNITI studies

摘要

著录项

相似文献

相关主题

期刊订阅